The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium
Open accessAbstract
Summary: The National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium is applying the latest generation of proteomic technologies to genomically annotated tumors from The Cancer Genome Atlas (TCGA) program, a joint initiative of the NCI and the National Human Genome Research Institute. By providing a fully integrated accounting of DNA, RNA, and protein abnormalities in individual tumors, these datasets will illuminate the complex relationship between genomic abnormalities and cancer phenotypes, thus producing biologic insights as well as a wave of novel candidate biomarkers and therapeutic targets amenable to verification using targeted mass spectrometry methods. Cancer Discov; 3(10); 1108–12. ©2013 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
MacLean, B., Tomazela, D. M., Shulman, N., Chambers, M., Finney, G. L., Frewen, B., Kern, R., Tabb, D. L., Liebler, D. C., & MacCoss, M. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq054 · Cited by 4,697
Self-citationA Model for Random Sampling and Estimation of Relative Protein Abundance in Shotgun Proteomics
Liu, H., Sadygov, R. G., & Yates, J. R. (2004) · Analytical Chemistry · doi:10.1021/ac0498563 · Cited by 2,500
Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
Picotti, P., & Aebersold, R. (2012) · Nature Methods · doi:10.1038/nmeth.2015 · Cited by 1,302
Addona, T. A., Abbatiello, S. E., Schilling, B., Skates, S. J., Mani, D. R., Bunk, D. M., Spiegelman, C. H., Zimmerman, L. J., Ham, A.-J. L., Keshishian, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1546 · Cited by 1,037
Self-citationTargeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer
Gallien, S., Duriez, E., Crone, C., Kellmann, M., Moehring, T., & Domon, B. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o112.019802 · Cited by 510
Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry
Gillette, M. A., & Carr, S. A. (2013) · Nature Methods · doi:10.1038/nmeth.2309 · Cited by 495
Self-citationWolf-Yadlin, A., Hautaniemi, S., Lauffenburger, D. A., & White, F. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608638104 · Cited by 493
Michalski, A., Damoc, E., Lange, O., Denisov, E., Nolting, D., Müller, M., Viner, R., Schwartz, J., Remes, P., Belford, M., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o111.013698 · Cited by 373
The Genomic Landscape of Breast Cancer as a Therapeutic Roadmap
Ellis, M. J., & Perou, C. M. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0462 · Cited by 229
Self-citationShi, T., Fillmore, T. L., Sun, X., Zhao, R., Schepmoes, A. A., Hossain, M., Xie, F., Wu, S., Kim, J.-S., Jones, N., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204366109 · Cited by 224
Self-citationiTRAQ Labeling is Superior to mTRAQ for Quantitative Global Proteomics and Phosphoproteomics
Mertins, P., Udeshi, N. D., Clauser, K. R., Mani, D., Patel, J., Ong, S.-E., Jaffe, J. D., & Carr, S. A. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014423 · Cited by 190
Self-citationRudnick, P. A., Clauser, K. R., Kilpatrick, L. E., Tchekhovskoi, D. V., Neta, P., Blonder, N., Billheimer, D. D., Blackman, R. K., Bunk, D. M., Cardasis, H. L., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900223-mcp200 · Cited by 183
Self-citationPhosphoproteomics Identifies Driver Tyrosine Kinases in Sarcoma Cell Lines and Tumors
Bai, Y., Li, J., Fang, B., Edwards, A., Zhang, G., Bui, M. M., Eschrich, S. A., Altiok, S., Koomen, J. M., & Haura, E. B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3015 · Cited by 137
Razavi, M., Frick, L. E., LaMarr, W. A., Pope, M. E., Miller, C. A., Anderson, N. L., & Pearson, T. W. (2012) · Journal of Proteome Research · doi:10.1021/pr300652v · Cited by 96
Zhang, G., Fang, B., Liu, R. Z., Lin, H., Kinose, F., Bai, Y., Oguz, U., Remily-Wood, E. R., Li, J., Altiok, S., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr1006203 · Cited by 70
Chen, Y., Gruidl, M., Remily-Wood, E. R., Liu, R. Z., Eschrich, S. A., Lloyd, M. C., Nasir, A., Bui, M. M., Huang, E. H., Shibata, D., et al. (2010) · Journal of Proteome Research · doi:10.1021/pr1005197 · Cited by 50
GeLC-MRM Quantitation of Mutant KRAS Oncoprotein in Complex Biological Samples
Halvey, P. J., Ferrone, C. R., & Liebler, D. C. (2012) · Journal of Proteome Research · doi:10.1021/pr300161j · Cited by 37
Self-citationLiu, Q., Halvey, P. J., Shyr, Y., Slebos, R. J. C., Liebler, D. C., & Zhang, B. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.025783 · Cited by 30
Self-citationMolecular Pathways: Extracting Medical Knowledge from High-Throughput Genomic Data
Goldstein, T. C., Paull, E., Ellis, M. J., & Stuart, J. M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2093 · Cited by 14
Self-citation
Cited by
Proteogenomics connects somatic mutations to signalling in breast cancer
CPTAC, N., Mertins, P., Mani, D. R., Ruggles, K. V., Gillette, M. A., Clauser, K. R., Wang, P., Wang, X., Qiao, J. W., Cao, S., et al. (2016) · Nature · doi:10.1038/nature18003 · Cited by 1,676
Self-citationIntegrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma
Gao, Q., Zhu, H., Dong, L., Shi, W., Chen, R., Song, Z., Huang, C., Li, J., Dong, X., Zhou, Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.052 · Cited by 1,096
Self-citationProteogenomics: concepts, applications and computational strategies
Nesvizhskii, A. I. (2014) · Nature Methods · doi:10.1038/nmeth.3144 · Cited by 770
Perseus: A Bioinformatics Platform for Integrative Analysis of Proteomics Data in Cancer Research
Tyanova, S., & Cox, J. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7493-1_7 · Cited by 661
How Machine Learning Will Transform Biomedicine
Goecks, J., Jalili, V., Heiser, L. M., & Gray, J. W. (2020) · Cell · doi:10.1016/j.cell.2020.03.022 · Cited by 582
Metadata
- Authors
- Ellis, M. J., Gillette, M., Carr, S. A., Paulovich, A. G., Smith, R. D., Rodland, K. K., Townsend, R. R., Kinsinger, C., Mesri, M., Rodriguez, H., & Liebler, D. C.
- Venue
- Cancer Discovery
- Published
- 2013-10-01
- Volume
- 3
- Issue
- 10
- Pages
- 1108-1112
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2155320075
- Cited by
- 309
- References
- 20
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.